Voya Investment Management LLC Sells 33,176 Shares of Privia Health Group, Inc. $PRVA

Voya Investment Management LLC lowered its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 40.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 49,078 shares of the company’s stock after selling 33,176 shares during the period. Voya Investment Management LLC’s holdings in Privia Health Group were worth $1,222,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Russell Investments Group Ltd. lifted its position in shares of Privia Health Group by 2,852.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after purchasing an additional 2,567 shares during the period. Trexquant Investment LP raised its stake in Privia Health Group by 65.5% in the first quarter. Trexquant Investment LP now owns 145,641 shares of the company’s stock worth $3,270,000 after buying an additional 57,652 shares in the last quarter. Royal Bank of Canada lifted its holdings in Privia Health Group by 63.5% in the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock worth $5,514,000 after buying an additional 95,371 shares during the period. PDT Partners LLC purchased a new stake in Privia Health Group in the first quarter worth about $1,942,000. Finally, AQR Capital Management LLC boosted its position in Privia Health Group by 24.7% during the 1st quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock valued at $916,000 after acquiring an additional 8,068 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Truist Financial reissued a “buy” rating and issued a $31.00 target price (up previously from $30.00) on shares of Privia Health Group in a research report on Monday, November 10th. Evercore ISI increased their price objective on Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, November 7th. Canaccord Genuity Group raised their price objective on Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, November 12th. Citizens Jmp upped their target price on shares of Privia Health Group from $30.00 to $31.00 and gave the stock a “market outperform” rating in a research report on Friday, November 7th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a research report on Monday. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $30.42.

Insider Buying and Selling at Privia Health Group

In other news, CFO David Mountcastle sold 23,887 shares of the company’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $25.03, for a total transaction of $597,891.61. Following the transaction, the chief financial officer directly owned 172,909 shares of the company’s stock, valued at $4,327,912.27. This represents a 12.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Matthew Shawn Morris sold 13,647 shares of Privia Health Group stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $25.01, for a total value of $341,311.47. Following the completion of the sale, the director owned 68,188 shares of the company’s stock, valued at $1,705,381.88. The trade was a 16.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 10.70% of the stock is owned by insiders.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $23.86 on Wednesday. The company has a 50-day simple moving average of $24.23 and a two-hundred day simple moving average of $22.88. Privia Health Group, Inc. has a 52-week low of $18.77 and a 52-week high of $26.51. The stock has a market capitalization of $2.93 billion, a PE ratio of 183.55, a price-to-earnings-growth ratio of 4.07 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The company had revenue of $213.61 million during the quarter. As a group, equities research analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.